Janux Therapeutics is developing safe, effective novel immunotherapies with the company’s proprietary TRACTr technology. Janux’s TRACTr technology employs a modular design to rapidly engineer drug candidates against specific targets. 

Biotechnology

Janux Therapeutics

David Campbell

Human Resources Manager

Associate Director, Quality Assurance

Associate Director, Analytical Development

Megan Shannon

Tommy DiRaimondo

Director, Human Resources

Zachariah McIver

Koho Iizuka

James Pennington

Sheila Gujrathi, MD

Nick Almaguer

Lina Ma

Hans Aerni

Yogesh Bramhecha, PhD

Sara Walsh

Natalija Van Braeckel Budimir

Jerry Warren

Carolina Caffaro

Charles Winter

Tighe Reardon

Byron Robinson

Andy Meyer

The Research and Development Team at Janux Therapeutics leverages the company’s proprietary TRACTr technology to engineer novel immunotherapies. Comprised of experts in fields such as immunology, bioanalytical development, biomarker discovery, and clinical operations, the team focuses on discovering, developing, and optimizing drug candidates against specific targets to ensure safety and efficacy. They collaborate across various specializations to conduct preclinical and clinical trials, analyze data, and advance promising therapies through the development pipeline.

Research and Development Team

Advisory Team

Leadership Team

Research and Development Team

About

Team members

Other teams at Janux Therapeutics

Advisory Team

Leadership Team